Sign In

Justin M Wright

Medical device and pharma executive

Justin M. Wright is the Vice President of Device, Packaging, and Process Development at Gilead Sciences, a position he has held since August 2023. He is based in the New York City Metropolitan Area and has a strong background in the pharmaceutical and medical device industries.

Professional Background

  • Current Role: As Vice President at Gilead Sciences, Wright oversees the development of devices, packaging, and sterile processes, contributing to the company's innovative drug delivery systems.
  • Previous Experience:
    • Global Head Connected Health (VP) at Novartis (November 2020 - March 2023): Led the connected health development portfolio and strategy.
    • Global Head of Innovation at Novartis (January 2018 - November 2020): Managed enterprise innovation across drug development for both biologics and small molecules.
    • Vice President, Drug Delivery Innovation at Eli Lilly and Company (June 2015 - January 2018): Focused on drug delivery innovation.
    • Held various roles at BD (Becton, Dickinson and Company) from Senior Director to Manager in pharmaceutical development and strategic innovation.

Education

  • PhD in Organic Chemistry from Clemson University (1995-2000).
  • Post-Doctoral Fellowship in Bio-Organic Chemistry at Harvard Medical School (1999-2000).
  • BS in Chemistry from Shenandoah University (1991-1995).

Wright's extensive experience in drug delivery systems and innovation within the pharmaceutical sector underscores his leadership capabilities in developing critical healthcare solutions.

Highlights

Apr 19 · linkedin

I have always felt privileged to be part of an industry dedicated to understanding and treating diseases. The opportunity to improve patients' and their families' lives has always motivated me. Yet, despite our tremendous progress in decoding diseases, there is still a long way to go. About a year ago, my children's mother lost a 30-year battle with mental illness. This tragic event was a stark reminder of disruptive innovation's importance in our industry and the courage to chase new ideas. I urge innovation leaders to create a safe space for their teams to explore and advance their ideas. And for innovators, I encourage you to pursue your ideas with dogmatic passion, even in the face of resistance, as this is how breakthroughs happen.

To honor his mother and give back to the community, my son runs the New York City marathon this fall and raises funds for Still I Run (stillirun.org). Still I Run is a community of runners and mental health warriors determined to take control of our physical and mental health while also breaking the stigma surrounding people living with mental illness. Please consider donating to my son's cause. https://lnkd.in/eZukevpw #digitalhealth #connectedhealth #innovation #mentalhealth #stillirun #nycmarathon #digitalbiomarkers

Feb 2 · linkedin

A great opportunity to join a growing team!

Related Questions

What are Justin M Wright's key achievements at Gilead Sciences?
How did Justin M Wright's role at Novartis differ from his role at Gilead Sciences?
What innovations has Justin M Wright led in the pharmaceutical industry?
What is Justin M Wright's educational background and how has it influenced his career?
What are the main challenges Justin M Wright has faced in his career?
Justin M Wright
Justin M Wright, photo 1
Justin M Wright, photo 2
Add to my network

Experience

Vice President, Device, Packaging, and Sterile Process Development at Gilead Sciences (August 2023 - Present)
Global Head Connected Health (VP) at Novartis (November 2020 - March 2023)

Education

Post-Doctoral Fellowship in Bio-Organic Chemistry at Harvard Medical School (1999 - 2000); PhD in Organic Chemistry at Clemson University (1995 - 2000); BS in Chemistry at Shenandoah University (1991

Location

New York City Metropolitan Area